- Home
- SNTI vs JSPR Comparison
SNTI vs JSPR Comparison
Compare SNTI & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- JSPR
- Stock Information
- Founded
- SNTI 2016
- JSPR 2018
- Country
- SNTI United States
- JSPR United States
- Employees
- SNTI N/A
- JSPR N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNTI Health Care
- JSPR Health Care
- Exchange
- SNTI Nasdaq
- JSPR Nasdaq
- Market Cap
- SNTI 85.3M
- JSPR 85.8M
- IPO Year
- SNTI N/A
- JSPR N/A
- Fundamental
- Price
- SNTI $3.56
- JSPR $5.70
- Analyst Decision
- SNTI Strong Buy
- JSPR Strong Buy
- Analyst Count
- SNTI 1
- JSPR 11
- Target Price
- SNTI $12.00
- JSPR $62.22
- AVG Volume (30 Days)
- SNTI 25.9K
- JSPR 204.2K
- Earning Date
- SNTI 05-06-2025
- JSPR 05-12-2025
- Dividend Yield
- SNTI N/A
- JSPR N/A
- EPS Growth
- SNTI N/A
- JSPR N/A
- EPS
- SNTI N/A
- JSPR N/A
- Revenue
- SNTI N/A
- JSPR N/A
- Revenue This Year
- SNTI N/A
- JSPR N/A
- Revenue Next Year
- SNTI N/A
- JSPR N/A
- P/E Ratio
- SNTI N/A
- JSPR N/A
- Revenue Growth
- SNTI N/A
- JSPR N/A
- 52 Week Low
- SNTI $1.52
- JSPR $3.13
- 52 Week High
- SNTI $16.94
- JSPR $26.84
- Technical
- Relative Strength Index (RSI)
- SNTI 58.08
- JSPR 61.07
- Support Level
- SNTI $3.04
- JSPR $4.57
- Resistance Level
- SNTI $3.25
- JSPR $6.20
- Average True Range (ATR)
- SNTI 0.23
- JSPR 0.42
- MACD
- SNTI 0.04
- JSPR 0.10
- Stochastic Oscillator
- SNTI 89.83
- JSPR 69.33
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.